Philippines Pharmaceuticals and Healthcare Report Q1 2014

Date: December 4, 2013
Pages: 126
Price:
US$ 1,295.00
Publisher: Business Monitor International
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P6B349D12C4EN
Leaflet:

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI is upgrading its generic drug market forecast on the back of greater acceptance of generic drugs coupled with progressive implementation of universal health coverage. As for the latter factor, we expect improvements in health-related infrastructure and the medical workforce in order to provide care for patients. The corresponding rise in the number of health facilities will spur demand for generic drugs and prescription drugs in general. Both factors will continue to provide opportunities for generic drug firms looking to expand in the Philippines. We highlight, however, that potential price containment policies and the current lack of health facilities are downside risks to our view.

Headline Expenditure Projections
  • Pharmaceuticals: PHP138.45bn (US$3.28bn) in total sales in 2013, rising to PHP143.38bn (US$3.37bn) in 2014; +3.6% in local currency terms and +2.9% in US dollar terms.
  • Healthcare: PHP520.23bn (US$12.32bn) in sales in 2013 rising to PHP583.48bn (US$13.373bn) in 2014; +12.1% in local currency terms and +11.5% in US dollar terms.
BMI Industry View
SWOT
Political
Economic
Business Environment
Industry Forecast
Pharmaceutical Market Forecast
  Table: Philippines Pharmaceutical Sales, Historical Data and Forecasts, 2009-2017
Healthcare Market Forecast
  Table: Philippines Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
  Table: Philippines Government Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
  Table: Philippines Private Healthcare Expenditure Trends, Historical Data and Forecasts, 2009-2017
Philippines
  Table: Philippines Prescription Drug Market Indicators, Historical Data and Forecasts, 2009-2017
Patented Drug Market Forecast
  Table: Philippines Patented Drug Market Indicators, Historical Data and Forecasts, 2009-2017
Generic Drug Market Forecast
  Table: Philippines Generics Drug Market Indicators, Historical Data and Forecasts, 2009-2017
OTC Medicine Market Forecast
  Table: Philippines Over-The-Counter (OTC) Medicine Market Indicators, Historical Data and Forecasts, 2009-2017
Pharmaceutical Trade
  Table: Philippines Pharmaceutical Trade Data And Forecasts (US$mn), 2009-2017
  Table: Philippines Pharmaceutical Trade Data And Forecasts (PHPmn), 2009-2017
Other Healthcare Data
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
External Malaise A Drag, But Support Seen In Remittances
Investment Boom On Solid Footing
GDP Upgrade Well Deserved, But Watch Out For Risks
Expenditure Breakdown
  Table: Philippines - Economic Activity
Industry Risk Reward Ratings
Asia Pacific Risk/Reward Ratings
Philippines Risk Reward Ratings
Market Overview
Industry Trends And Developments
Regulatory Development
  Table: History Of Food And Drugs Administration
  Table: Medicines Subject To March 31 2010 Government Mediated Access Price
Competitive Landscape
  Table: Pharmaceutical Industry Overview
  Table: Overview Of BnB, BNB and P100 Programme
  Table: Cost Of Generic Drugs In Philippines (PHP)
  Table: Number Of BnBs and BNBs In Selected Philippine Regions
Company Profile
Unilab
Pascual Laboratories
Pacific Pharma Generics
MediChem Pharmaceuticals
GlaxoSmithKline Philippines
Pfizer
Novartis
Merck & Co
Sanofi
Demographic Forecast
Demographic Outlook
  Table: The Philippines' Population By Age Group, 1990-2020 ('000)
  Table: The Philippines' Population By Age Group, 1990-2020 (% of total)
  Table: The Philippines' Key Population Ratios, 1990-2020
  Table: The Philippines' Rural And Urban Population, 1990-2020
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Ratings Methodology
Ratings Overview
  Table: Pharmaceutical Risk/Reward Ratings Indicators
Indicator Weightings

Ask Your Question

Philippines Pharmaceuticals and Healthcare Report Q1 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: